iiinova — where your digital self keeps evolving

Reposted by Moritz Spangemacher

Max Wolff @trpwolff.bsky.social · 31/03/2026

Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression” osf.io/preprints/ps... Many thanks to my coauthors Rick Zeifman, @kangaslampi.bsky.social & @moeswisdom.bsky.social

osf.io

OSF

163

Reposted by Moritz Spangemacher

Tom Taylor @tomtaylormade.bsky.social · 09/07/2025

What a headline.

Superman Isn’t Trying to Be Political. We Just Have Real-Life Supervillains Now.

240268476168

Moritz Spangemacher @moeswisdom.bsky.social · 24/06/2025

NY Times Ballot - Best Movies of the Century so far

010

Reposted by Moritz Spangemacher

Max Wolff @trpwolff.bsky.social · 16/06/2025

Reframing Psychedelic Regulation: Tools, not Treatments In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right. The use of anesthetics as treatment tools in surgery is a useful analogy.

Drug Science, Policy and Law
Screenshot of title page and abstract

2248

Reposted by Moritz Spangemacher

Awais Aftab @awaisaftab.bsky.social · 03/05/2025

My opinion piece in today’s @nytimes.com . I discuss how clinical neglect of medication-related harms has made RFK Jr’s stance on antidepressants appealing to so many and moving the public conversation in a productive direction requires us to remedy this neglect. www.nytimes.com/2025/05/03/o...

nytimes.com

Opinion | What Kennedy Gets Right, And Wrong, About Antidepressants (Gift Article)

Harm from these drugs is real. Let’s not cede the conversation to Kennedy.

97530

Reposted by Moritz Spangemacher

eLife @elife.bsky.social · 23/03/2025

Research is investigating the medicinal applications of #psilocybin, with studies showing how #psychedelics can promote neuronal plasticity. This ‘fundamental’ study into the effects of #psilocin on human neurons: buff.ly/f7cNemV

Cortical neurons imaged by immunofluorescence

0148

Reposted by Moritz Spangemacher

Rich Haridy @richharidy.bsky.social · 19/03/2025

Another null result psychedelic trial. This time looking at LSD microdosing for ADHD. Most interesting is the detail showing most subjects in LSD group correctly guessed they got the psychedelic. BUT their benefits still mostly matched the placebo group.

jamanetwork.com

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults

This double-blind, placebo-controlled randomized clinical trial determines the safety and efficacy of repeated low doses of lysergic acid diethylamide (LSD) in reducing attention-deficit/hyperactivity...

265

Reposted by Moritz Spangemacher

Mario Sixtus @sixtus.net · 06/02/2025

Wenig überraschend ist die größte inhaltliche Übereinstimmung der CDU mit einer anderen Partei, die, mit der AfD. Das macht gemeinsames Abstimmen natürlich mindestens verlockend und lässt es ganz natürlich erscheinen. www.spiegel.de/politik/wahl...

14515156

Reposted by Moritz Spangemacher

Jules Evans @philosojules.bsky.social · 02/02/2025

First suicide in legal PAT, in Switzerland (first known case out of around 2000). History of delusions could be a red flag, not clear what the previous delusions and how psychosis-like they were. Thanks to the team for publishing this. www.sciencedirect.com/science/arti...

sciencedirect.com

Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report

082

Reposted by Moritz Spangemacher

david ehrlich @davidehrlich.bsky.social · 13/01/2025

THE 25 BEST FILMS OF 2024 A video countdown vimeo.com/1046284152

1132584584

Reposted by Moritz Spangemacher

Lea Mertens @leamert.bsky.social · 08/12/2024

Glad to be at #ACNP2024 in Phoenix! On Monday, I will be presenting the results of our episode trial in the session „Psychedelic-assisted Psychotherapy: From preclinical mechanisms to clinical applications“ alongside @fredbarrettphd.bsky.social, @kellietamashiro.bsky.social and Jennifer Mitchell.

083